[1] |
DeSantis C, Ma J, Bryan L, et al.Breast cancer statistics,2013[J].CA Cancer J Clin,2014,64(1):52-62.
|
[2] |
Andre F, Slimane K, Bachelot T, et al.Breast cancer with synchronous metastases: trends in survival during a 14-year period[J].J Clin Oncol,2004,22(16):3302-3308.
|
[3] |
Chia SK, Speers CH, D’Yachkova Y, et al.The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer[J].Cancer,2007,110(5):973-979.
|
[4] |
Pusceddu C, Capobianco G, Meloni F, et al.CT-guided cryoablation of both breast cancer and lymph node axillary metastasis[J].Eur J Gynaecol Oncol,2011,32(2):224-225.
|
[5] |
Niu L, Chen J, Yao F, et al.Percutaneous cryoablation for stage Ⅳlung cancer:a retrospective analysis[J].Cryobiology,2013,67(2):151-155.
|
[6] |
Mu F, Niu L, Li H, et al.Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer[J].Cryobiology,2013,66(1):76-80.
|
[7] |
Kapoor A, Touma NJ, Dib RE.Review of the efficacy and safety of cryoablation for the treatment of small renal masses[J].Can Urol Assoc J,2013,7(1/2):E38-44.
|
[8] |
Bomers JG,Yakar D, Overduin CG, et al.MR imaging-guided focal cryoablation in patients with recurrent prostate cancer[J].Radiology,2013,268(2):451-460.
|
[9] |
Kalinski P, Edington H, Zeh HJ, et al.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?[J].Immunol Res,2011,50(2/3):235-247.
|
[10] |
Hontscha C, Borck Y, Zhou H, et al.Clinical trials on CIK cells: first report of the international registry on CIK cells(IRCC)[J].J Cancer Res Clin Oncol,2011,137(2):305-310.
|
[11] |
Chen AP, Setser A, Anadkat MJ, et al.Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0 [J].J Am Acad Dermatol,2012,67(5):1025-1039.
|
[12] |
Tichy JR, Lim E, Anders CK.Breast cancer in adolescents and young adults: a review with a focus on biology[J].J Natl Compr Canc Netw,2013,11(9):1060-1069.
|
[13] |
Li XD, Xu B,Wu J,et al.Review of Chinese clinical trials on CIK cell treatment for malignancies[J].Clin Transl Oncol,2012,14(2):102-108.
|
[14] |
Thanendrarajan S, Nowak M, Abken H, et al.Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one? [J].Leuk Res,2011,35(9):1136-1142.
|
[15] |
Plate J.Clinical trials of vaccines for immunotherapy in pancreatic cancer[J].Expert Rev Vaccines,2011, 10(6):825-836.
|
[16] |
Sabel MS.Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses[J].Cryobiology,2009,58(1):1-11.
|
[17] |
Schnurr M, Scholz C, Rothenfusser S, et al.Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells[J].Cancer Res,2002,62(8):2347-2352.
|
[18] |
Rovere-Querini P, Manfredi AA.Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancer[J].JOP,2004,5(4):308-314.
|